Efficacy and safety of anti-TNF therapies in psoriatic arthritis: an observational study from the British Society for Rheumatology Biologics Register.

Rheumatology (Oxford, England)

Volumn 49, Issue 4, 2010, Pages 697-705

  Saad, Amr A ^a   Ashcroft, Darren M ^b   Watson, Kath D ^b   Symmons, Deborah P M ^b   Noyce, Peter R ^b   Hyrich, Kimme L ^b   BSRBR, ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ANTIRHEUMATIC AGENT; INFLIXIMAB; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

AGED; ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; DRUG ANTAGONISM; EVALUATION; FEMALE; HOSPITALIZATION; HUMAN; MALE; MIDDLE AGED; PSORIATIC ARTHRITIS; QUESTIONNAIRE; REGRESSION ANALYSIS; TREATMENT OUTCOME;

AGED; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, PSORIATIC; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; QUESTIONNAIRES; REGRESSION ANALYSIS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77953480860     PISSN: None     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kep423     Document Type: Article

References (0)